المؤلفون: de Vos-Geelen, J, Hoebers, FJP, Geurts, SME, Hoeben, A, de Greef, BTA, Voncken, FEM, Bogers, JHA, Braam, PM, Muijs, CKT, de Jong, WM, Kasperts, N, Rozema, T, Jeene, PM, Blom, GJ, Dieren, JM, Hulshof, MC, van Laarhoven, HW, Grabsch, HI, Lemmens, Valery, Tjan-Heijnen, VC, Nieuwenhuijzen, GA

المصدر: de Vos-Geelen , J , Hoebers , FJP , Geurts , SME , Hoeben , A , de Greef , BTA , Voncken , FEM , Bogers , JHA , Braam , PM , Muijs , CKT , de Jong , WM , Kasperts , N , Rozema , T , Jeene , PM , Blom , GJ , Dieren , JM , Hulshof , MC , van Laarhoven , HW , Grabsch , HI , Lemmens , V , Tjan-Heijnen , VC & Nieuwenhuijzen , GA 2020 , ' A national study to assess outcomes of definitive chemoradiation regimens in proximal esophageal cancer ' , Acta Oncologica , vol. 59 , no. 8 , pp. 895-903 .

مصطلحات الفهرس: dk/atira/pure/keywords/researchprograms/AFL001000/EMCNIHES026501; name=EMC NIHES-02-65-01, dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; name=SDG 3 - Good Health and Well-being, article

URL: https://pure.eur.nl/en/publications/e0209c7e-3d43-4c6c-bfcc-55e38e48c3b0

المؤلفون: Claessens, AKM, Ibragimova, KIE, Geurts, SME, Bos, Monique, Erdkamp, FLG, Tjan-Heijnen, VC

المصدر: Claessens , AKM , Ibragimova , KIE , Geurts , SME , Bos , M , Erdkamp , FLG & Tjan-Heijnen , VC 2020 , ' The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practice ' , Critical Reviews in Oncology/Hematology , vol. 153 , 102988 .

مصطلحات الفهرس: dk/atira/pure/keywords/researchprograms/AFL001000/EMCOR01; name=EMC OR-01, dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; name=SDG 3 - Good Health and Well-being, article

URL: https://pure.eur.nl/en/publications/aca237c0-0697-4919-b6ee-dc62b6a1b3ed

المؤلفون: Aarts, AMWM, Duffy, SW, Geurts, SME, Vulkan, DP, Otten, JDM, Hsu, C-Y, Chen, THH, Verbeek, ALM, Broeders, MJM

المصدر: Journal of Medical Screening; Sep2019, Vol. 26 Issue 3, p147-153, 7p, 2 Charts

مصطلحات موضوعية: BREAST tumor prevention, MAMMOGRAMS, MEDICAL technology, DISEASE incidence, DESCRIPTIVE statistics, EARLY detection of cancer

مصطلحات جغرافية: NETHERLANDS

المؤلفون: van Kessel, Kim, Geurts, SME, Verbeek, ALM, Steyerberg, Ewout, Johnson, FE, Maehara, Y, Browman, GP, Margenthaler, JA, Audiso, RA, Thompson, JF, Johnson, DY, Earle, CC, Virgo, K

المساهمون: Public Health

المصدر: Patient Surveillance After Cancer Treatment

مصطلحات موضوعية: SDG 3 - Good Health and Well-being

URL الوصول: https://explore.openaire.eu/search/publication?articleId=narcis______::1ad87a1d0ca2615c3b7276cf30aaefed
https://pure.eur.nl/en/publications/d09687a9-ba18-40fc-9cdc-13cace1b3d57

المؤلفون: Meegdes M; Department of Internal Medicine, Division of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, The Netherlands., van der Velde MGAM; Department of Internal Medicine, Maxima Medical Center, Veldhoven, The Netherlands., Geurts SME; Department of Internal Medicine, Division of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, The Netherlands., van Kats MACE; Department of Internal Medicine, Division of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, The Netherlands., Dercksen MW; Department of Internal Medicine, Maxima Medical Center, Veldhoven, The Netherlands., Tjan-Heijnen VCG; Department of Internal Medicine, Division of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, The Netherlands.

المصدر: Journal of chemotherapy (Florence, Italy) [J Chemother] 2024 Jul; Vol. 36 (4), pp. 343-350. Date of Electronic Publication: 2023 Nov 09.

نوع المنشور: Journal Article; Case Reports

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 8907348 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1973-9478 (Electronic) Linking ISSN: 1120009X NLM ISO Abbreviation: J Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Cyclin-Dependent Kinase 4*/antagonists & inhibitors , Cyclin-Dependent Kinase 6*/antagonists & inhibitors , Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Protein Kinase Inhibitors*/therapeutic use, Humans ; Female ; Middle Aged ; Male ; Aged ; Breast Neoplasms, Male/drug therapy ; Breast Neoplasms, Male/pathology ; Pyridines/therapeutic use ; Piperazines/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Liver Neoplasms/secondary ; Liver Neoplasms/drug therapy ; Adult

المؤلفون: Lammers SWM; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands., Geurts SME; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands., Hermans KEPE; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands., van Hellemond IEG; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands., Swinkels ACP; Clinical Research Department, Netherlands Comprehensive Cancer Organisation (IKNL), Nijmegen, the Netherlands., Smorenburg CH; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Sangen MJC; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands., Honkoop AH; Department of Medical Oncology, Isala Clinics, Zwolle, the Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre Heerlen-Sittard-Geleen, location Sittard-Geleen, Geleen, the Netherlands., de Roos WK; Department of Surgery, Gelderse Vallei Hospital, Ede, the Netherlands., Imholz ALT; Department of Medical Oncology, Deventer Hospital, Deventer, the Netherlands., Vriens IJH; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands. vcg.tjan.heijnen@mumc.nl.

مؤلفون مشاركون: Dutch Breast Cancer Research Group (BOOG) for the DATA investigators

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jun 28. Date of Electronic Publication: 2024 Jun 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

المؤلفون: Geurts SME; Department of Medical Oncology, GROW- School for Oncology and Reproduction, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands. sandra.geurts@mumc.nl., Ibragimova KIE; Department of Medical Oncology, GROW- School for Oncology and Reproduction, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands., Ding N; Department of Medical Oncology, GROW- School for Oncology and Reproduction, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands., Meegdes M; Department of Medical Oncology, GROW- School for Oncology and Reproduction, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands., Erdkamp F; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, The Netherlands., Heijns JB; Department of Medical Oncology, Amphia, Breda, The Netherlands., Tol J; Department of Medical Oncology, Jeroen Bosch Hospital, Den Bosch, The Netherlands., Vriens BEPJ; Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands., Dercksen MW; Department of Medical Oncology, Máxima Medical Center, Eindhoven, The Netherlands., Aaldering KNA; Department of Internal Medicine, Laurentius Hospital, Roermond, The Netherlands., Pepels MJAE; Department of Internal Medicine, Elkerliek Hospital, Helmond, The Netherlands., van de Winkel L; Department of Internal Medicine, St Anna Hospital, Geldrop, The Netherlands., Peters NAJB; Department of Internal Medicine, Sint Jans Gasthuis Hospital, Weert, Netherlands., van de Wouw AJ; Department of Internal Medicine, Viecuri Medical Centre, Venlo, The Netherlands., Maaskant SAJG; Department of Surgery, Máxima Medical Center, Eindhoven, The Netherlands., Teeuwen-Dedroog NJA; Department of Medical Oncology, GROW- School for Oncology and Reproduction, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands., van Nijnatten TJA; Department of Radiology and Nuclear Medicine, GROW, Maastricht University Medical Center, Maastricht, The Netherlands., de Boer M; Department of Medical Oncology, GROW- School for Oncology and Reproduction, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, GROW- School for Oncology and Reproduction, Maastricht University Medical Center, PO BOX 5800, 6202 AZ, Maastricht, The Netherlands.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jun; Vol. 205 (2), pp. 287-302. Date of Electronic Publication: 2024 Feb 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/mortality , Breast Neoplasms*/pathology , Breast Neoplasms*/therapy , Receptor, ErbB-2*/metabolism , Registries*, Humans ; Female ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Neoplasm Metastasis ; Kaplan-Meier Estimate ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use

المؤلفون: Lammers SWM; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, Maastricht. Electronic address: senna.lammers@mumc.nl., Meegdes M; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, Maastricht., Vriens IJH; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, Maastricht., Voogd AC; Department of Epidemiology, Maastricht University, Maastricht., de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht., van Nijnatten TJA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, GROW, Maastricht., Keymeulen KBMI; Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, Maastricht., Geurts SME; Department of Medical Oncology, Maastricht University Medical Centre, GROW, Maastricht University, Maastricht. Electronic address: sandra.geurts@mumc.nl.

المصدر: ESMO open [ESMO Open] 2024 May; Vol. 9 (5), pp. 103008. Date of Electronic Publication: 2024 Apr 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/mortality , Breast Neoplasms*/pathology , Breast Neoplasms*/therapy , Breast Neoplasms*/metabolism , Receptor, ErbB-2*/metabolism, Humans ; Female ; Netherlands/epidemiology ; Middle Aged ; Retrospective Studies ; Aged ; Adult ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Survival Rate ; Aged, 80 and over ; Triple Negative Breast Neoplasms/mortality ; Triple Negative Breast Neoplasms/therapy ; Triple Negative Breast Neoplasms/pathology

المؤلفون: Ibragimova KIE; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Geurts SME; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Laczkó D; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands., Meegdes M; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Erdkamp F; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, The Netherlands., Heijns JB; Department of Medical Oncology, Amphia, Breda, The Netherlands., Tol J; Department of Medical Oncology, Jeroen Bosch Hospital, Den Bosch, The Netherlands., Vriens BEPJ; Department of Internal Medicine, Catharina hospital, Eindhoven, The Netherlands., Aaldering KNA; Department of Internal Medicine, Laurentius hospital, Roermond, The Netherlands., Dercksen MW; Department of Medical Oncology, Máxima Medical Center, Eindhoven, The Netherlands., Pepels MJAE; Department of Internal Medicine, Elkerliek hospital, Helmond, The Netherlands., Peters NAJB; Department of Internal Medicine, St. Jans Gasthuis, Weert, The Netherlands., van de Winkel LMH; Department of Internal Medicine, St Anna Hospital, Geldrop, The Netherlands., van de Wouw AJ; Department of Internal Medicine, Viecuri Medical Centre, Venlo, The Netherlands., de Fallois A; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands., van Kats MACE; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands. Electronic address: vcg.tjan.heijnen@mumc.nl.

المصدر: Clinical breast cancer [Clin Breast Cancer] 2024 Feb; Vol. 24 (2), pp. 103-111. Date of Electronic Publication: 2023 Nov 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology, Humans ; Female ; Trastuzumab ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Receptor, ErbB-2/metabolism ; Progression-Free Survival ; Proportional Hazards Models

المؤلفون: de Wilde AJ; Department of Surgery, Maastricht University Medical Centre+, Maastricht, the Netherlands., de Jong EJM; Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Centre+, GROW, Maastricht University, Maastricht, the Netherlands., Gurusamy KS; Division of Surgery and Interventional Science, Royal Free Campus, University College London, London, UK., Abu Hilal M; Department of Surgery, Fondazione Poliambulanza, Brescia, Italy., Besselink MG; Amsterdam UMC, location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands.; Cancer Centre Amsterdam, Amsterdam, the Netherlands., Dewulf MJL; Department of Surgery, Maastricht University Medical Centre+, Maastricht, the Netherlands., Geurts SME; Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Centre+, GROW, Maastricht University, Maastricht, the Netherlands., Neumann UP; Department of Surgery, Maastricht University Medical Centre+, Maastricht, the Netherlands., Olde Damink SWM; Department of Surgery, Maastricht University Medical Centre+, Maastricht, the Netherlands., Poley JW; Department of Gastroenterology and Hepatology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Tjan-Heijnen VCG; Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Centre+, GROW, Maastricht University, Maastricht, the Netherlands., de Vos-Geelen J; Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Centre+, GROW, Maastricht University, Maastricht, the Netherlands., Wiltberger G; Department of General, Visceral, and Transplantation Surgery, University Hospital of RWTH Aachen, Aachen, Germany., Coolsen MME; Department of Surgery, Maastricht University Medical Centre+, Maastricht, the Netherlands., Bouwense SAW; Department of Surgery, Maastricht University Medical Centre+, Maastricht, the Netherlands.

المصدر: The British journal of surgery [Br J Surg] 2024 Jan 03; Vol. 111 (1).

نوع المنشور: Journal Article; Systematic Review

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0372553 Publication Model: Print Cited Medium: Internet ISSN: 1365-2168 (Electronic) Linking ISSN: 00071323 NLM ISO Abbreviation: Br J Surg Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma*, Humans ; Biopsy ; Cross-Sectional Studies ; Endoscopy ; Endosonography